Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Pidolic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pidolic Acid SCHEMBL1239532 | 1.00 | CAD (0.46) | — | |
| Pidolic Acid SCHEMBL29479230 | 1.00 | — | — | |
| Pidolic Acid SCHEMBL10937920 | 1.00 | CAD (0.46) | — | |
| Pidolic Acid SCHEMBL15791 | 1.00 | — | — | |
| Pidolic Acid SCHEMBL152441 | 1.00 | CAD (0.46) | — | |
| Pidolic Acid SCHEMBL15790 | 1.00 | — | — | |
| Pidolic Acid SCHEMBL7554345 | 1.00 | CAD (0.46) | — | |
| Pidolic Acid SCHEMBL30872192 | 0.98 | CAD (0.44) | — | |
| Pidolic Acid SCHEMBL10875923 | 0.98 | CAD (0.44) | — | |
| Pidolic Acid SCHEMBL21693635 | 0.98 | CAD (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119936394-B | Diagnostic system for abdominal aortic aneurysm and application thereof | BEIJING FRIENDSHIP HOSPITAL, CAPITAL MEDICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12630520-B2 | Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2026-05-19 | — | — | US | claimed |
| EP-4709401-A1 | ORAL DELIVERY OF PLANT DERIVED VESICLES AND USES THEREOF | Board of Regents, The University of Texas System (US) | 2026-03-18 | — | — | EP | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-12503449-B2 | Methods of preparing chiral benzodiazepinone derivatives | IMMUNOME, INC. (US) | 2025-12-23 | — | — | US | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-3606525-B1 | COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS USING CCR3-INHIBITORS | ALKAHEST INC (US) | 2025-12-10 | — | — | EP | claimed |
| US-12473251-B2 | Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-11-18 | — | — | US | claimed |
| US-20250346565-A1 | METHODS OF PREPARING CHIRAL BENZODIAZEPINONE DERIVATIVES | AYALA PHARMACEUTICALS INC. | 2025-11-13 | — | — | US | claimed |
| EP-0768309-A1 | Process for the preparation of enantiomerically pure imidazolyl compounds | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1997-04-16 | — | — | EP | claimed |
| US-5618948-A | TREATMENT OF 6-CARBOXAMIDO-3-METHYLAMINO-1,2,3,4-TETRAHYDROCARBAZOLE WITH 2-PYRROLIDONE-5-CARBOXYLIC ACID, CRYSTALLIZATION | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-04-08 | — | — | US | claimed |
| US-5508385-A | PROTEASE INHIBITOR; ANTIULCER AGENTS, ANTIINFLAMMATORY AGENTS; TREATING PANCREATITIS | NITTO BOSEKI CO., LTD. (JP) | 1996-04-16 | — | — | US | claimed |
| EP-0444482-B1 | Oxetanones | HOFFMANN LA ROCHE (CH) | 1996-01-17 | — | — | EP | claimed |
| EP-0436005-B1 | LABELED POLYPEPTIDE DERIVATIVES | SANDOZ LTD (CH) | 1995-03-29 | — | — | EP | claimed |
| EP-0436005-A1 | LABELED POLYPEPTIDE DERIVATIVES. | SANDOZ LTD (CH) | 1991-07-10 | — | — | EP | claimed |
| WO-1991001144-A1 | LABELED POLYPEPTIDE DERIVATIVES | SANDOZ LTD (CH) | 1991-02-07 | — | — | WO | claimed |
| WO-1989009786-A1 | PEPTIDE DERIVATIVES | SANDOZ AG (CH) | 1989-10-19 | — | — | WO | claimed |
| WO-1988002756-A2 | PEPTIDE DERIVATIVES | SANDOZ AG (CH) | 1988-04-21 | — | — | WO | claimed |
| US-4575509-A | AMSACRINE | BRISTOL-MYERS COMPANY (US) | 1986-03-11 | — | — | US | claimed |